Resmed (RSMDF) Acquisitions (2009 - 2026)

Resmed (RSMDF) has reported Acquisitions for 17 consecutive years, with $325.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Acquisitions rose 134.76% year-over-year to $325.3 million; the trailing twelve-month figure through Jun 2026 stood at $350.7 million (up 150.33% YoY), and the FY2026 full-year result was $350.7 million, up 150.33% from the prior year.
• Acquisitions advanced to $325.3 million in Q2 2026 per RSMDF's latest filing, from $24.9 million in the prior quarter.
• Across five years, Acquisitions topped out at $992.1 million in Q4 2022 and bottomed at $522000.0 in Q3 2025.
• Historically, Acquisitions has averaged $117.7 million across 5 years, with a median of $13.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Acquisitions surged 2662.43% in 2022, then tumbled 99.24% in 2023.
• Over 5 years, Acquisitions stood at $992.1 million in 2022, then sank by 99.24% to $7.5 million in 2023, then sank by 91.07% to $670000.0 in 2024, then dropped by 22.09% to $522000.0 in 2025, then jumped by 62221.65% to $325.3 million in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $325.3 million, $24.9 million, and $522000.0 for Q2 2026, Q1 2026, and Q3 2025 respectively.